TCL Archive Kennedy Plans One Year Act Renewal, Followed By Three Year Bill; Hearing Scheduled Feb. 8 February 3, 1978
TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010
TCL Archive FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic September 10, 1976
TCL Archive Controversy Raging On Whether To Release Data On 5-FU/Levamisole, Stop Untreated Control Arm June 9, 1989
